Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Jun 9, 2014

CGI to Perform Cancer Dx Testing in Central America, Caribbean for AstraZeneca

CGI to Perform Cancer Dx Testing in Central America, Caribbean for AstraZeneca

Source: © Guillaume Le Bloas - Fotolia.com

  • AstraZeneca CAMCAR, a division of AZ that serves Central American and Caribbean countries, has tapped Cancer Genetics (CGI) to provide diagnostic testing based on biomarkers for cancer. CGI will perform complex testing for diagnosis and prognosis of cancer patients in Central America and the Caribbean. Per the agreement, CGI will be working closely with AZ-CAMCAR on exploring opportunities to expand into additional geographic territories, more cancer categories, and into select oncology trials.

    This partnership, the firms say, will focus on multiple cancer categories starting with lung cancer, as the Pan American Health Organization expects cases and deaths from lung cancer to double in Latin America by 2030.

    "We believe our ability to provide accurate, state-of-the-art biomarker-based testing was a key factor in AstraZeneca’s decision to partner with us, and serves as a testament to the growing global awareness of the value of our brand." CGI's CEO Panna Sharma said in a statement. "We are committed to positively impacting cancer care globally, and this relationship serves as another major milestone in fulfilling that mission."

    Also as part of that mission, last month CGI picked up India-based company BioServe Biotechnologies for about $1.9 million with the aim of helping CGI scale up its genetic analysis, bioinformatics, and manufacturing operations while capitalizing on clinical diagnostics and trial growth in India and the Asian market.



Related content

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

Be sure to take the GEN Poll

What Does Brexit Mean for Biotech?

Do you agree with the contention that Brexit will NOT have a long-term negative impact on the British biotech industry?

More »